McCune-Albright syndrome.
Feuillan
P P
PP
National Institutes of Health, Bethesda, Maryland, USA.
D000293:Adolescent; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D005260:Female; D005359:Fibrous Dysplasia, Polyostotic / Q000628:therapy*; D006801:Humans; D008297:Male; D011629:Puberty, Precocious / Q000628:therapy; D013738:Testolactone / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D013738:Testolactone